Hipolin (530853)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹112.25 |
| Market Cap | ₹36.85 Cr |
| P/E Ratio | 0 |
| ROCE | -24.64% |
| ROE | -27.83% |
| Dividend Yield | 0% |
| Profit Growth | 89.47% |
| Debt/Equity | — |
| Sales Growth | -25.4% |
| 52-Week Range | ₹44.83 — ₹116.93 |
| Sector | Household Products |
| Book Value | ₹40.77 |
Strengths
- Piotroski F-Score of 5/9 indicates some basic financial-health metrics are positive.
- Reported profit growth of 89.47% shows improvement from a very weak base.
- Latest quarter is near breakeven with net profit of ₹0 Cr, not deteriorating into a large loss.
- Positive book value of ₹40.77 provides a residual asset base.
Concerns
- ROE of -27.83% and ROCE of -24.64% show serious shareholder value destruction.
- Sales growth of -25.40% means the business is shrinking.
- P/E of 0.00 and latest quarter net profit of ₹0 Cr confirm no real current earnings.
- At P/B of 2.75, market price is far above book value with no margin of safety and no dividend yield.
AI Analysis
Let me start with the obvious: I do not buy businesses I cannot value, and I certainly don't buy them at a premium when they are destroying capital. Hipolin is a ₹37 Cr microcap in the household products space. Sales fell 25.4% in the latest year, and the latest quarter brought only ₹4 Cr of revenue with no net profit. A P/E of 0.00 tells you that earnings are absent today. Yes, reported profit growth is +89.47%, but when you start from a loss or a zero base, percentages are meaningless. Look at the returns. ROE is -27.83%, ROCE -24.64%. Every rupee retained in the business is earning a loss. Graham would demand a margin of safety. At ₹112.25, the stock trades at 2.75 times book value of ₹40.77. That is not asset value investing; that is paying a rich price for poor economics. There is no dividend yield to compensate while waiting. Household products is a competitive, low-moat industry. Without scale or brand pricing power, a small player has little protection. Piotroski F-Score of 5/9 is mediocre, not a green light. The 52-week range shows price has risen from ₹44.83 to near ₹116.93, but price action is not evidence of intrinsic value. I cannot rely on promoter holding data because it is not disclosed here; that only adds uncertainty. A true value investor should be patient and demanding. I want to see several quarters of positive earnings, a halt in the revenue decline, and a price that offers some discount to the asset base. None of those conditions are met today. This is a possible turnaround, but the burden of proof is on the business, not on my imagination. I will pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer